Session detail

Back to the session list

Session type
Thursday, April 25th 2019
Session time
09h00 - 10h30
ROOM 151
Martine BAGOT (France)
Julia SCARISBRICK (United Kingdom)
Rudolf STADLER (Germany)
09h00 - 09h15
Tumor clone frequency is a robust predictor of progression and survival in patients with early stage mycosis fungoides
Adèle DE MASSON (France)
09h15 - 09h30
International landscape of therapies in CTCL, Results of the PROCLIPI Study
Pietro QUAGLINO (Italy)
09h30 - 09h45
Therapeutic Strategies for improved management in CTCL
Rudolf STADLER (Germany)
09h45 - 10h00
New monoclonal antibodies for the treatment of CTCL
Martine BAGOT (France)
10h00 - 10h15
Clinical endpoints updates and considerations for future staging
Julia SCARISBRICK (United Kingdom)
10h15 - 10h30
Management of Cutaneous B cell lymphoma
Antonio COZZIO (Switzerland)

By continuing to browse this website, you accept cookies which are used to offer a personalized experience on our website, generate statistics and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Ok Read more